1. Synthesis, Spectroscopic Analyses, Chemical Reactivity and Molecular Docking Study and Anti-tubercular Activity of Pyrazine and Condensed Oxadiazole Derivatives. Al-Tamimi, A.-M.S., Y.S. Mary, P.B. Miniyar, L.H. Al-Wahaibi, A.A. El-Emam, S. Armakovic, and S.J. Armakovic. Journal of Molecular Structure, 2018. 1164: p. 459-469. ISI[000431470400053].
[WOS]. TB_05_2018.
2. Microwave-assisted Synthesis of Novel Pyrazole Clubbed Polyhydroquinolines in an Ionic-liquid and Their Biological Perspective. Bhatt, J.D., T.S. Patel, C.J. Chudasama, and K.D. Patel. ChemistrySelect, 2018. 3(13): p. 3632-3640. ISI[000430102300010].
[WOS]. TB_05_2018.
3. Antibacterial and anti-Tb Tat-peptidomimetics with Improved Efficacy and Half-life. Bhosle, G.S., L. Nawale, A.M. Yeware, D. Sarkar, and M. Fernandes. European Journal of Medicinal Chemistry, 2018. 152: p. 358-369. PMID[29738954].
[PubMed]. TB_05_2018.
4. Biological Evaluation and Synthesis of New Pyrimidine-2(1H)-ol/-thiol Derivatives Derived from Chalcones Using the Solid Phase Microwave Method. Fandakli, S., N. Kahriman, T.B. Yucel, S. Alpay Karaoglu, and N. Yayli. Turkish Journal of Chemistry, 2018. 42(2): p. 520-535. ISI[000431245300026].
[WOS]. TB_05_2018.
5. An Efficient Buchwald-Hartwig/Reductive Cyclization for the Scaffold Diversification of Halogenated Phenazines: Potent Antibacterial Targeting, Biofilm Eradication, and Prodrug Exploration. Garrison, A.T., Y. Abouelhassan, D. Kallifidas, H. Tan, Y.S. Kim, S. Jin, H. Luesch, and R.W. Huigens, III. Journal of Medicinal Chemistry, 2018. 61(9): p. 3962-3983. PMID[29638121].
[PubMed]. TB_05_2018.
6. Anti-tuberculosis Potential, Pharmacological and Phytochemical Studies of Methanolic Extracts from Selected Plant Species. Gulfraz, M., M. Shah, H. Gul, S.M. Bukhari, K. Ashraf, M. Azeem, and F.A. Khan. Acta Poloniae Pharmaceutica, 2017. 74(6): p. 1761-1766. ISI[000430449500016].
[WOS]. TB_05_2018.
7. Propylene-1H-1,2,3-triazole-4-methylene-tethered Isatin-Coumarin Hybrids: Design, Synthesis, and in Vitro Anti-tubercular Evaluation.Huang, G.-C., Y. Xu, Z. Xu, Z.-S. Lv, J. Zhang, H.-Y. Guo, Y.-Q. Hu, M.-L. Liu, J. Guan, and Y. Lu. Journal of Heterocyclic Chemistry, 2018. 55(4): p. 830-835. ISI[000430179800005].
[WOS]. TB_05_2018.
8. Diversity, Novelty, and Antimicrobial Activity of Endophytic Actinobacteria from Mangrove Plants in Beilun Estuary National Nature Reserve of Guangxi, China. Jiang, Z.-k., L. Tuo, D.-l. Huang, I.A. Osterman, A.P. Tyurin, S.-w. Liu, D.A. Lukyanov, P.V. Sergiev, O.A. Dontsova, V.A. Korshun, F.-n. Li, and C.-h. Sun. Frontiers in Microbiology, 2018. 9(868): 11pp. PMID[29780376]. PMCID[PMC5945994].
[PubMed]. TB_05_2018.
9. Indole propionic acid: A Small Molecule Links between Gut Microbiota and Tuberculosis. Kaufmann, S.H.E. Antimicrobial Agents and Chemotherapy, 2018. 62(5): e00389-00318. PMID[29700005]. PMCID[PMC5923146].
[PubMed]. TB_05_2018.
10. Molecular Modeling Studies and anti-Tb Activity of Trisubstituted indolizine Analogues; Molecular Docking and Dynamic Inputs. Khedr, M.A., M. Pillay, S. Chandrashekharappa, D. Chopra, B.E. Aldhubiab, M. Attimarad, O.I. Alwassil, K. Mlisana, B. Odhav, and K.N. Venugopala. Journal of Biomolecular Structure & Dynamics, 2018. 36(8): p. 2163-2178. PMID[28657441].
[PubMed]. TB_05_2018.
11. Identification of Tb-E12 as a Novel FtsZ Inhibitor with Anti-tuberculosis Activity. Lin, Y., H. Zhang, N. Zhu, X. Wang, Y. Han, M. Chen, J. Jiang, and S. Si. Tuberculosis, 2018. 110: p. 79-85. PMID[29779778].
[PubMed]. TB_05_2018.
12. Design, Synthesis and Antitubercular Evaluation of Benzothiazinones Containing a Piperidine Moiety. Lv, K., Z. Tao, Q. Liu, L. Yang, B. Wang, S. Wu, A. Wang, M. Huang, M. Liu, and Y. Lu. European Journal of Medicinal Chemistry, 2018. 151: p. 1-8. PMID[29601990].
[PubMed]. TB_05_2018.
13. Antimicrobial and Chemotactic Activity of Scorpion-derived Peptide, ToAP2, against Mycobacterium massiliensis.Marques-Neto, L.M., M.M. Trentini, R.C. das Neves, D.P. Resende, V.O. Procopio, A.C. da Costa, A. Kipnis, M.R. Mortari, E.F. Schwartz, and A.P. Junqueira-Kipnis. Toxins, 2018. 10(219): 13pp. PMID[29848960].
[PubMed]. TB_05_2018.
14. Antimycobacterial Activity of Marine Sargassum swartzii Extracts against Mycobacterium tuberculosis.Mathayan, M., R. Sundar, and S. Anbarasu. Bangladesh Journal of Pharmacology, 2018. 13(2): p. 130-131. ISI[000431193700003].
[WOS]. TB_05_2018.
15. Protic Ionic Liquid Promoted One Pot Synthesis of 2-Amino-4-(phenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile Derivatives in Water and Their Antimycobacterial Activity. Mohire, P.P., D.R. Chandam, R.B. Patil, D.R. Kumbhar, S.J. Jadhav, A.A. Patravale, V.P. Godase, J.S. Ghosh, and M.B. Deshmukh. Journal of Heterocyclic Chemistry, 2018. 55(4): p. 1010-1023. ISI[000430179800030].
[WOS]. TB_05_2018.
16. Synthesis and in Vitro Studies of Thiazolidine-4-carboxylic acid hydrazones as Potential Antitubercular Agents. Nagasree, K.P., M.M.K. Kumar, Y.R. Prasad, D. Sriram, and P. Yogeeswari. Indian Journal of Chemistry Section B-Organic Chemistry Including Medicinal Chemistry, 2018. 57(4): p. 538-555. ISI[000430640200003].
[WOS]. TB_05_2018.
17. Identification of Potent Chromone Embedded 1,2,3-Triazoles as Novel Anti-tubercular Agents. Nalla, V., A. Shaikh, S. Bapat, R. Vyas, M. Karthikeyan, P. Yogeeswari, D. Sriram, and M. Muthukrishnan. Royal Society Open Science, 2018. 5(171750): 15pp. PMID[29765644]. PMCID[PMC5936909].
[PubMed]. TB_05_2018.
18. Microwave Assisted Synthesis and SAR Studies of Novel Hybrid Phenothiazine Analogs as Potential Antitubercular Agents. Pemmadi, R.V., P.N. Kurre, P.V.S. Guruvelli, R.N. Jamullamudi, and M.K.K. Muthyala. Indian Journal of Chemistry Section B-Organic Chemistry Including Medicinal Chemistry, 2018. 57(4): p. 556-566. ISI[000430640200004].
[WOS]. TB_05_2018.
19. Graph Theoretical Analysis, in Silico Modeling, Synthesis, Anti-microbial and anti-Tb Evaluation of Novel Quinoxaline Derivatives. Saravanan, G., T.P. Selvam, V. Alagarsamy, S. Kunjiappan, S.D. Joshi, M. Indhumathy, and P.D. Kumar. Drug Research, 2018. 68(5): p. 250-262. PMID[29065435].
[PubMed]. TB_05_2018.
20. Alkylated/Aminated Nitroimidazoles and Nitroimidazole-7-chloroquinoline Conjugates: Synthesis and Anti-mycobacterial Evaluation. Shalini, A. Viljoen, L. Kremer, and V. Kumar. Bioorganic & Medicinal Chemistry Letters, 2018. 28(8): p. 1309-1312. PMID[29551480].
[PubMed]. TB_05_2018.
21. Antimycobacterial Potential of Resorcinol Type Lipid Isolated from Chaetomium cupreum, an Endophytic Fungus from Mussaenda luteola. Shylaja, G., K. Sasikumar, and A. Sathiavelu. Bangladesh Journal of Pharmacology, 2018. 13(2): p. 114-119. ISI[000431193700001].
[WOS]. TB_05_2018.
22. Identification of Mycobacterium tuberculosis BioA Inhibitors by Using Structure-based Virtual Screening.Singh, S., G. Khare, R.K. Bahal, P.C. Ghosh, and A.K. Tyagi. Drug Design, Development and Therapy, 2018. 12: p. 1065-1079. PMID[29750019]. PMCID[PMC5935190].
[PubMed]. TB_05_2018.
23. Design and Synthesis of 9H-Fluorenone Based 1,2,3-Triazole Analogues as Mycobacterium Tuberculosis InhA Inhibitors.Suresh, A., S. Srinivasarao, N. Agnieszka, A.-K. Ewa, M. Alvala, C. Lherbet, and K.V.G.C. Sekhar. Chemical Biology & Drug Design, 2018. 91(6): p. 1078-1086. PMID[29063733].
[PubMed]. TB_05_2018.
24. Dibenzofuran, Dibenzothiophene and N-Methyl carbazole Tethered 2-Aminothiazoles and Their Cinnamamides as Potent Inhibitors of Mycobacterium tuberculosis. Surineni, G., S.K. Marvadi, P. Yogeeswari, D. Sriram, and S. Kantevari. Bioorganic & Medicinal Chemistry Letters, 2018. 28(9): p. 1610-1614. PMID[29598909].
[PubMed]. TB_05_2018.
25. Discovery of Novel Anti-tuberculosis Agents with Pyrrolo[1,2-a]quinoxaline-based Scaffold. Wang, T., Y. Tang, Y. Yang, Q. An, Z. Sang, T. Yang, P. Liu, T. Zhang, Y. Deng, and Y. Luo. Bioorganic & Medicinal Chemistry Letters, 2018. 28(11): p. 2084-2090. PMID[29748048].
[PubMed]. TB_05_2018.
26. Evaluation of Sulphonamide Derivatives Acting as Inhibitors of Human Carbonic Anhydrase Isoforms I, II and Mycobacterium tuberculosis Beta-class Enzyme Rv3273. Wani, T.V., S. Bua, P.S. Khude, A.H. Chowdhary, C.T. Supuran, and M.P. Toraskar. Journal of Enzyme Inhibition and Medicinal Chemistry, 2018. 33(1): p. 962-971. PMID[29772937].
[PubMed]. TB_05_2018.
27. Synthesis and Evaluation of Antimicrobial, Antitubercular and Anticancer Activities of 2-(1-Benzoyl-1H-benzo[d]imidazol-2-ylthio)-N-substituted acetamides. Yadav, S., S.M. Lim, K. Ramasamy, M. Vasudevan, S.A.A. Shah, A. Mathur, and B. Narasimhan. Chemistry Central Journal, 2018. 12(1): p. 66. PMID[29804151].
[PubMed]. TB_05_2018.
Patent Citations
28. Screening Methods for Identifying DNA Primase and Gyrase Inhibitors and Therapeutic Uses Thereof.Akabayov, B. Patent. 2018. 2017-IL51155 2018073828: 99pp.
[Patent]. TB_05_2018.
29. 3-Triazenoindoles Exhibiting Antimycobacterial Activity. Apt, A.S., V.S. Velezheva, B.V. Nikonenko, A.G.e. Kornienko, K.B. Majorov, P.Y.e. Ivanov, T.K. Kondratieva, M.V.y. Korotetskaya, and E.G. Salina. Patent. 2018. 2016-RU765 2018088920: 22pp.
[Patent]. TB_05_2018.
30. Methods for the Treatment or Prevention of Mycobacterial Infections. Pethe, K., G. Pluschke, N. Scherr, and R. Bieri. Patent. 2018. 2017-SG50553 2018084809: 87pp.
[Patent]. TB_05_2018.